atherosclerosis

(Wiley-Blackwell) Atorvastatin therapy was found to be ineffective in reducing atherosclerosis progression in children and adolescents with systemic lupus erythematosus (SLE).

Results of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus Trial, now available in Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology, report that the statin therapy did trend toward positive effect of treatment and may benefit patients with more severe SLE who were not included in the trial.

MONTREAL (MedPage Today) -- HIV infection is a risk factor for atherosclerosis that is as important as traditional vascular risks such as smoking, a researcher said here.